chartexchange

CRY
GraniteShares YieldBOOST CRCL ETF
stockNASDAQETF

At CloseOct 7, 2026 1:14:39 PM EDT
15.56USD-1.269%(+15.56)9,798
Loading…
Loading…
510.08M
Healthcare
Medical Devices
CEO
James Mackin
HQ
Kennesaw, GA, USA
Previous Close
$15.60
Beta
0.41
52-Week High
$25.93 2026-05-11
52-Week Low
$15.39 2026-10-09
SMA 50
$16.98
SMA 200
$19.95
Avg. Vol 10D
9,701
Avg. Vol 30D
9,899
Avg. Vol 90D
8,880
Relative Vol
1.00
36.31M
7.7600%
1,931
Dec 9, 2015 · $0.030
Dec 28, 2000 · 3-for-2
CRY Profile

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.

CRY Performance
PeriodPriceDateChangeBeta
1W15.432026-10-02+1.35%1.114
1M17.232026-09-10-9.24%-0.023
3M18.712026-07-10-16.40%0.366
6M24.962026-04-28-37.33%0.411
5Y21.352021-10-11-26.75%-0.105
CRY Stock Summary

GraniteShares YieldBOOST CRCL ETF (NASDAQ:CRY) stock price today is $15.64, and today's volume is 9,900. CRY is up 0.237% today. The 30 day average volume is 9,899. CRY market cap is $510.08M with 32.61M shares outstanding.